Fig. 4From: Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptidePreexisting and AE37-induced immunity to PSA153 in HLA-A24+ patients. Vaccinations induced, in a statistically significant manner, CD8+/PSA153 + cells (a). Frequencies of CD8+/PSA153 + cells at each time point (R0, R3, R6 and LT) (b). Representative dot plots for negative control, R0 and Rmax for patients PR14, PR15, PR16 (c-e)Back to article page